Using a device to stimulate the trigeminal nerve for treating ADHD in children
Official title: External Trigeminal Nerve Stimulation Versus Sham Stimulation for Attention Deficit Hyperactivity Disorder in Children and Adolescents Aged 7-17 Years: Study Protocol for a Pilot and Feasibility Randomized Clinical Trial
Run by Psychiatric Research Unit, Region Zealand, Denmark · NCT06655610 · Data updated 2026-11-12
This study is testing whether a device that stimulates a nerve in the head can help children and teens with ADHD feel better without using medication.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 7 Years to 17 Years |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | Psychiatric Research Unit, Region Zealand, Denmark Academic / other |
| Locations | 1 site (Slagelse, Region Sjælland) |
| Status | Recruiting |
| Started | December 5, 2024 |
| Main results expected | August 31, 2026 |
| Study ends | November 25, 2026 |
| Registry record updated | March 9, 2026 |
| Trial ID | NCT06655610 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are children and adolescents aged 7 to 17 years with a clinical diagnosis of ADHD.
✕Probably not a fit
Patients currently receiving atomoxetine or guanfacine, or those with epilepsy or electronic/metallic implants, will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This trial evaluates the feasibility of using the Monarch external trigeminal nerve stimulation (eTNS) device as a non-pharmacological treatment for children and adolescents aged 7 to 17 years diagnosed with ADHD. Participants will be randomly assigned to receive either the active eTNS device or a sham device for four weeks during nighttime. Throughout the trial, families will complete questionnaires and maintain logbooks to track their experiences and symptoms. The study aims to assess treatment compliance, completion rates, and gather feedback from families to determine the potential for a larger clinical trial.
Why it matters
Potential benefit: If successful, this approach could provide a non-invasive treatment option for children with ADHD, reducing reliance on medication.
How similar studies have gone: While the use of eTNS for ADHD is relatively novel, previous studies have indicated its potential effectiveness, warranting further investigation.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * 7 to 17 years of age at the time of study enrollment. * A clinical diagnosis of ADHD according to criteria for ICD-10: F90.0, F91.0, F90.8, F90.9, F98.8C. The ADHD diagnosis must be verified by the Diagnostic and Statistical Manual for Mental Disorders (DSM-5) using The Schedule for Affective Disorders and Schizophrenia for School-aged Children (K-SADS). * A score above 24 on the ADHD rating scale (ADHD-RS) at baseline. * Signed informed consent from parents/legal caretakers and from the patients aged ≥ 15. We will include treatment-naïve patients, patients who previously have received stimulant medication, and patients in stable, ongoing stimulant medication (methylphenidate or dexamphetamines/lisdexamphetamine) during the time of the trial. Exclusion Criteria: * Patients receiving atomoxetine and guanfacine at the time of study enrollment will be excluded all together * Epilepsy * Electronic or metallic implants. * Serious mental and/or somatic diseases other than ADHD, such as: * Pervasive developmental disorder not including Asperger's syndrome (ICD-10 F84.0-84.4 + F84.8-84.9) * Schizophrenia/paranoid psychosis (ICD-10 F20-25 + F28-29) * Mania or bipolar disorder (ICD-10 F30 and F31) * Depressive psychotic disorders (ICD-10 F32.3 + F33.3) * Substance dependence syndrome (ICD-10 F1x.2) * Cardio-vascular disorders * Cancer * An Intelligence quotient (IQ) below 70 measured by the Wechsler Intelligence Scale for Children * A substantial degree of restless sleep as reported by parents or caregivers and evaluated by the physician. * Other disabilities that may make use of Monarch problematic.
Where it's running
-
Center for Evidence-Based Psychiatry, Psychiatric Research Unit, Psychiatry Region Zealand, 4200 Slagelse, Denmark
Slagelse, Region Sjælland, Denmark Recruiting
Study contacts
- Principal investigator: Ole Jakob Storebø, Professor — Center for Evidence-Based Psychiatry, Psychiatric Research Unit, Psychiatry Region Zealand, 4200 Slagelse, Denmark
- Study coordinator: Ole Jakob Storebø, Professor
- Email: ojst@regionsjaelland.dk
- Phone: 452-496-5917
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
AI-assisted home-based mood diary for kids with ADHD
A home-based program uses an AI-assisted diary that turns daily mood entries into comic strips to see if it helps kids with ADHD improve emotion regulation.
-
Medication effects on eye movements and autonomic function in children and teens with ADHD
This study tests how ADHD medication influences eye movements and autonomic nervous system signals in kids and teens with ADHD.
-
Medication treatment for ADHD in children with epilepsy
This study tests whether a stimulant medicine (Jornay PM) helps ADHD symptoms in children who also have epilepsy.
-
Retail-grade weighted blanket for sleep in children with ADHD
This study tests whether using a retail-grade weighted blanket for 4 weeks helps children with ADHD sleep better.
-
MOCHA: Inpatient Mental Health Care for High-Risk Pregnancy
This study tests a collaborative mental health program for pregnant or recently postpartum patients hospitalized for medical problems to see if it can be delivered feasibly and acceptably.
-
ADRIS 2.1 driving simulator for adolescents with ADHD.
This project will test whether the ADRIS 2.1 driving simulator can measure and train driving-related skills in adolescents aged 13–18 with ADHD.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.